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Abstract
BACKGROUND: One of the main indications for DSN is a diagnosis of obstructive uro-/nephropathy. In standard practice, 
this study includes the assessment of sequential scintigraphic images, renographic curves and such quantitative parameters 
as TMAX, T1/2 and split function of each kidney (SF). Due to the relative nature of SF and limitations of diagnostic capabilities of 
TMAX and T1/2, DSN was expanded to include new quantitative parameters describing kidney function in absolute values. This 
study aims to evaluate the usefulness of kidney efficiency index (KEi) — new, in-house developed parameter proportional to 
the average clearance function of the kidney.
MATERIAL AND METHODS: The study included 156 people aged 18–84 (average 51) years. The first group, from which 
normative values of new parameters were determined, consisted of 20 healthy volunteers. The second group consisted of 136 
patients selected retrospectively, based on archived scintigraphic data. “Normalcy rate” (percentage of normal results among 
selected 62 patients with a low likelihood of obstructive uro-/nephropathy) was used to evaluate the reliability of KEi. A com-
parative differential analysis of obstructive uro-/nephropathy, based on standard and new DSN parameters, was performed 
on selected 74 patients (92 kidneys) with single functioning kidney or bilateral obstructive uropathy, where SF is unreliable.
RESULTS: Normative values: KEi ≥ 8; Normalcy rate for KEi: 95%. In comparison with standard DSN evaluation, application of KEi 
changed the diagnosis in 1/3 of assessed kidneys (from uropathy to nephropathy in 27/92 kidneys and vice versa in 4 kidneys).
CONCLUSIONS: KEi enables reproducible, quantitative assessment of absolute kidney function without any modifications 
of the standard DSN protocol. Its values can be compared between independent studies (e.g. follow-up examinations). KEi 
corrected the diagnosis of obstructive uro-/nephropathy in cases of single functioning kidney or bilateral obstructive uropathy.
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Introduction
Dynamic renal scintigraphy (DRS) allows the evaluation of 
two functions of the kidney — uptake function and transport 
function. Interpretation of this study consists of visual assess-
ment of sequential scintigraphic images, renographic curves and 
analysis of quantitative parameters, such as an individual contri-
bution of each kidney to their total function (SF — split function) 
as well as times TMAX and T1/2 [1–3].
SF is the most important quantitative parameter in the standard 
DRS study and is often critical when making crucial clinical deci-
sions (e.g. qualification of patients for nephrectomy). However, 
it has a significant limitation. Due to the fact that it shows the 
function of one kidney relative to the other, there are situations in 
which its value loses credibility, e.g. when assessing the function 
of a single kidney, or in case of disorders affecting both kidneys. 
Due to significant, often fundamental importance of DRS in mak-
ing decisions about further management of patients, there are 
attempts to expand this study with additional parameters allowing 
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the assessment and monitoring of absolute renal function also in 
the above-mentioned situations.
One such option is to determine the value of glomerular filtra-
tion rate (GFR) and compare it with SF to calculate single-kidney 
GFR (SKGFR) [4]. However, this requires additional radioisotope 
studies of blood samples taken from the patient after intrave-
nous administration of the radiopharmaceutical (99mTc-DTPA), 
which are not widely available. Assessment of renal function in 
absolute values within the DRS itself, without the need for additional 
tests, is made possible by calculating clearance of radiopharma-
ceuticals using gamma-cameras (camera-based clearance), but 
its determination requires extending the DRS protocol by accurate 
measurement of injected activity and the depth of kidneys [5, 6].
This study evaluates the diagnostic potential of a new, origi-
nal parameter — Kidney Efficiency index (KEi), generated using 
software developed in our Department [7, 8], that allows the 
assessment of renal function in absolute values, but without the 
need for additional tests or modification of the standard DRS 
protocol. A model clinical problem for analyzing the usefulness of 
the above-mentioned parameters is the differential diagnosis of 
obstructive uro- and nephropathy, which is the most common 
indication for DRS.
Material and methods
The study covered 156 people aged 18–84 (average 51) years.
The subjects were separated into two groups. Group I — con-
trol, consisting of 20 healthy, adult volunteers (40 kidneys), which 
was used to determine normative values of evaluated parameters. 
Inclusion criteria for this group were as follows:
 — no history of past or ongoing urinary tract diseases or other 
conditions that may lead to impaired renal function (such 
as systemic lupus, diabetes or uncontrolled hypertension)
 — no features of urolithiasis, hydronephrosis, scarring or other 
focal lesions (e.g. cysts) in the kidneys in ultrasound, performed 
on the same day as DRS
 — serum urea and creatinine levels within normal limits in tests per-
formed on the same day as DRS
Group II included 136 adult patients, retrospectively selected 
from among those who underwent DRS in our Department in the 
years 2016–2019, based on archived medical documentation, 
including full data from the DRS study. In total, 216 kidneys were 
assessed (some patients from group IIB had only one functioning 
kidney). This group consisted of:
Subgroup IIA — 62 patients without scintigraphic features of 
obstructive uropathy or nephropathy (124 kidneys)
Subgroup IIB — 74 patients with no or trace function of one 
kidney (defined as SF < 10%); or with features of obstructive 
uropathy of both kidneys in standard study (92 kidneys in total)
Demographic data of all examined groups is summarized in 
Table 1.
All subjects underwent DRS performed according to the 
standard protocol used in our Department. All subjects drank 
0.5 l of water about 30 minutes before the study and urinated just 
before commencing image acquisition. DRS was performed in the 
supine position using one of the GE scintillation cameras: Infinia 
Hawkeye 1, Infinia Hawkeye 4 or Optima NM/CT 640, equipped with 
low-energy general-purpose collimators (LEGP), after administra-
tion of standard activity of 111 MBq 99mTc-EC [9, 10]. Field of view of 
the detectors covered both the kidneys and the heart of the subject 
and the images were recorded in a 128 x 128 pixel matrix. In case 
of a significantly slowed down urine outflow, i.e. renographic curve 
remaining above 30% of the peak level for the entirety of the base 
study (20 min.), DRS was extended by a diuretic test, carried out in 
accordance with the “F+20” protocol for additional 10 minutes [11].
Routine visual assessment of 2-minute sequential scintigraphic 
images and renographic curves were performed in all subjects, 
as well as the assessment of basic quantitative parameters ob-
tained after conventional scintigraphic data processing. In group 
II, kidneys with features of obstructive uropathy or nephropathy 
were distinguished on this basis. Kidneys meeting at least 2 of 
the following 3 criteria were considered nephropathic: SF < 42%, 
TMAX > 7 min. or presence of uptake defect(s) in the peripheral part 
of the kidney cortex determined as a consensus by two special-
ists based on visual assessment of sequential images obtained 
in the uptake phase. On the other hand, absence of renographic 
curve decrease, or its decrease by less than 50% from the end of 
the case study after the diuretic test, were considered as features of 
obstructive uropathy (total or incomplete obstructive uropathy, 
respectively).
Afterwards, additional post-processing of scintigraphic data 
was performed, using the ImageJ program with the original plugin 
developed in our Department. The method of determining ROIs of 
heart, kidneys and extrarenal background was shown in the work 
by Filipczak et al. [7, 8]. ROIs plotted in this way were then used 
to generate time-activity curves showing changes of the radiop-
harmaceutical concentration in the heart and kidneys (the latter 
being corrected by subtracting non-renal background activity). 
These curves served as the basis for the calculation of all assessed 
parameters.
Based on Rutland’s theory [12], uptake constant K was de-
termined for each kidney [7, 8]. Its value is proportional to the 
Table 1. Demographic data of all examined groups
Number of people (number of kidneys in parentheses) and their sex Age
Total Women Men Min. Max. Avg. ± SD
Group I 20 (40) 15 5 26 66 50 ± 11
Group II 136 (216) 94 42 18 84 52 ± 18
Subgroup IIA 62 (124) 48 14 18 79 48 ± 17
Subgroup IIB 74 (92) 46 28 18 84 57 ± 19
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clearance function of a kidney. Then the average value of this pa-
rameter per pixel of whole kidney ROI was calculated, to make it in-
dependent from the size of the organ, which leads to obtaining KEi.
Reliability of assessed parameters was evaluated in multiple 
ways. KEi values, as shown in work by Filipczak et al. [7, 8]. were 
strongly correlated with single-kidney eGFR (SKeGFR), where eGFR 
was calculated using the CKD-EPI formula [13–15] and multiplying 
it by SF value of each kidney.
“Normalcy rate” — the percentage of results within the normal 
range (according to normative values determined in the group of 
healthy volunteers) in group IIA, that is, in patients with no scinti-
graphic features of uropathy or obstructive nephropathy in standard 
DRS, was also used as a verification of the reliability of the method.
Next, a comparative analysis of the differentiation of obstructive 
uro-/nephropathy was performed based on standard and new DRS 
parameters in IIB subgroup, i.e. in situations where SF is unreliable.
Statistica version 13.1 was used for statistical analysis. Nor-
mality of data distributions was tested using Shapiro-Wilk’s test. 
In group I, the distribution of KEi values was normal, while values of 
TMAX deviated from normal distribution. In group II and each of 
its subgroups, values of both parameters deviated from normal 
distribution. The statistical significance level (p) used in the study 
was 0.05.
Results
Due to normal distribution of KEi values in the control group (I), 
its normative value was assumed as mean — 2 standard deviations, 
while for TMAX, mean + 3 standard deviations were taken as normal 
limit. The results are summarized in Table 2.
KEi was within normal range in 118/124 kidneys from subgroup 
IIA (with very low probability of obstructive uro-/nephropathy) 
— “normalcy rate” 95%. The distribution of KEi values in group 
I and subgroup IIA was very similar (Fig. 1A and 1B, respectively).
In subgroup IIB (patients with bilateral uropathy or single 
active kidney), according to the standard DRS criteria assumed 
in this study, obstructive uropathy was found in 18/92 kidneys, 
and obstructive nephropathy was diagnosed in 25/92 kidneys. 
Distribution of KEi values in this subgroup was significantly dif-
ferent than in groups of healthy kidneys (Fig. 1C). Use of KEi 
changed the qualification in 31/92 kidneys (1/3) — in 4 cases (4%) 
corrected the qualification from nephropathy to uropathy, while 
in 27 cases (29%) KEi was below normal limit despite of lack of 
features of nephropathy in the evaluation of standard scintigraphic 
parameters (Fig. 2).
Table 2. Values of assessed parameters in examined groups with 
assumed normative limits
TMAX [min] KEi
Group I 3,6 ± 1,1 12,78 ± 2,46
Normal limits < 7 ≥ 8
Group II
Subgroup IIA 4,4 ± 2,2 12,20 ± 2,87
Subgroup IIB 13,8 ± 11,3 9,32 ± 5,45
Figure 1A. Distribution of KEi values in kidneys from group I
Figure 1B. Distribution of KEi values in kidneys from subgroup IIA
Figure 1C. Distribution of KEi values in kidneys from subgroup IIB
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of standard scintigraphic data. Hence it can be used both routinely, 
or only in cases in which assessment of classic DSN param-
eters does not provide a conclusive diagnosis. It can also be ap-
plied retrospectively with ease, for example for scientific purposes.
One of the important arguments supporting the usefulness of 
this parameter, apart from its strong correlation with SKeGFR shown 
in work by Filipczak et al. [7, 8], is its high normalcy rate. In a group 
of patients with a very low probability of uropathy or nephropathy 
according to the standard DSN evaluation — subgroup IIA, KEi 
also showed values within the normal range in 95% of cases and 
the distribution of its values was very similar to group I. This con-
firms the accuracy of the normative limit established on a selected 
group of healthy volunteers. Distribution of KEi values in subgroup 
IIB, which consisted of both normally functioning and nephropathic 
kidneys, was significantly different.
Value of KEi, that represents the average clearance function 
of a kidney, is completely independent of its size. This allows de-
termination of normative values, based on a group of healthy 
volunteers with no impairments of kidney function, that can later 
be used for evaluation of other kidneys, regardless of their size. 
This parameter can be useful not only in the diagnosis of obstruc-
tive nephropathy, but also for the differentiation of a small, but 
normally functioning (hypoplastic) kidney from an insufficient one 
(e.g. cirrhotic), and in assessing a small kidney in the diagnosis of 
renovascular hypertension. This will be the subject of our further 
research.
In summary, it should be noted that KEi extends the capabili-
ties of DRS with a repeatable, quantitative assessment of absolute, 
individual kidney function. This parameter does not require any 
modifications of a routine protocol of the study (and thus can be 
determined in post-processing, e.g. only if the standard DRS result 
is ambiguous). It was shown that use of this parameter improves the 
diagnostic effectiveness of DSN in the differential diagnosis of 
obstructive uropathy and nephropathy.
References
1.  Taylor AT, Brandon DC, de Palma D, et al. SNMMI Procedure Stand-
ard/EANM Practice Guideline for Diuretic Renal Scintigraphy in Adults 
With Suspected Upper Urinary Tract Obstruction 1.0. Semin Nucl Med. 
2018; 48(4): 377–390, doi: 10.1053/j.semnuclmed.2018.02.010, indexed 
in Pubmed: 29852947.
2. Durand E, Blaufox MD, Britton KE, et al. International Scientific Commit-
tee of Radionuclides in Nephrourology (ISCORN). International Scientific 
Committee of Radionuclides in Nephrourology (ISCORN) consensus on 
renal transit time measurements. Semin Nucl Med. 2008; 38(1): 82–102, 
doi: 10.1053/j.semnuclmed.2007.09.009, indexed in Pubmed: 18096466.
3. Taylor A, Nally JV. Clinical applications of renal scintigraphy. AJR Am J 
Roentgenol. 1995; 164(1): 31–41, doi: 10.2214/ajr.164.1.7998566, indexed 
in Pubmed: 7998566.
4. Piepsz A, Dobbeleir A, Erbsmann F. Measurement of separate kidney 
clearance by means of 99mTc-DTPA complex and a scintillation camera. 
European Journal of Nuclear Medicine. 1977; 2(3), doi: 10.1007/bf00257276.
5. Schlegel JU, Halikiopoulos HL, Prima R. Determination of filtration fraction 
using the gamma scintillation camera. J Urol. 1979; 122(4): 447–450, doi: 
10.1016/s0022-5347(17)56457-5, indexed in Pubmed: 480482.
6. Gates GF. Glomerular filtration rate: estimation from fractional renal accu-
mulation of 99mTc-DTPA (stannous). AJR Am J Roentgenol. 1982; 138(3): 
565–570, doi: 10.2214/ajr.138.3.565, indexed in Pubmed: 7039273.
Figure 2. Change of kidney qualification in group IIB based on the 
values of KEi
There were 3 patients qualified as bilateral uropathy, whose 
kidneys had SF well within normal ranges and displayed no 
significant uptake defects, while KEi showed features of bilateral 
nephropathy. In the group of patients with single functioning kidney, 
in 7 cases KEi changed the classification to nephropathy while all 
3 standard criteria suggested normal function of the kidney, that 
is SF was between 90 and 100%, TMAX between 3 and 6 min. and 
visual assessment revealed no uptake defects at all.
Discussion
SF, which is the main quantitative parameter of DRS, due to 
its relative nature has significant limitations reducing its useful-
ness in certain clinical situations. In case of bilateral renal dys-
function or only a single functioning kidney, reliable assessment 
of renal function is only possible by supplementing SF with the 
value of GFR of a given patient. However, this requires performing 
additional studies, e.g. using accurate, but time-consuming and 
labor-intensive methods for determining glomerular filtration with 
radioisotopes (99mTc-DTPA clearance) or as a simpler, but less ac-
curate method for calculating estimated GFR using biochemical 
studies (e.g. serum creatinine level).
Therefore, methods that allow an assessment of renal cortex 
function in absolute values are being developed, based only on 
scintigraphic data obtained with gamma-cameras in DRS, without 
the need for taking blood samples or urine collection. Several 
such protocols have been created and camera-based clearance 
methods are even an integral part of modern scintillation camera 
software. However, for these techniques acquisition of additional 
- non-standard data is necessary, as described in the work by Filip-
czak et al. [7, 8], which in turn requires modification and expansion 
of the standard DRS protocol.
Original parameter KEi does not have these disadvantages. It 
is relatively easy to determine and relies only on post-processing 
Nuclear Medicine Review 2020, Vol. 23, No. 2
www.journals.viamedica.pl/nuclear_medicine_review82
Original
7. Filipczak K, Cichocki P, Surma M, et al. Renal Clearance Function 
Index-a New Quantitative Parameter of a Dynamic Renal Scintigraphy. Eur 
J Nucl Med Mol Imaging. 2019; 46: 243–4.
8. Filipczak K, Cichocki P, Kuśmierek J, et al. Kidney Efficiency Index - Quantita-
tive Parameter of a Dynamic Renal Scintigraphy. I. Theory and Verification. 
Nucl Med Rev. 2020; 23(2).
9. Surma MJ, Wiewiórka J, Szadkowska A, et al. Pharmacokinetic character-
istics of 99mTc-Ethylene-l-dicysteine (99mTc-EC). Nucl Med Rev Cent East 
Eur. 1999; 2(1): 20–27, indexed in Pubmed: 14600996.
10. Surma MJ, Wiewióra J, Liniecki J. Usefulness of 99Tcm-N,N’-ethylene-1-di-
cysteine complex for dynamic kidney investigations. Nucl Med Commun. 
1994; 15(8): 628–635, doi: 10.1097/00006231-199408000-00007, indexed 
in Pubmed: 7970444.
11. O’Reilly P, Aurell M, Britton K, et al. Consensus on diuresis renography for 
investigating the dilated upper urinary tract. Radionuclides in Nephrourology 
Group. Consensus Committee on Diuresis Renography. J Nucl Med. 1996; 
37(11): 1872–1876, indexed in Pubmed: 8917195.
12. Rutland MD. A comprehensive analysis of renal DTPA studies. I. 
Theory and normal values. Nucl Med Commun. 1985; 6(1): 11–20, doi: 
10.1097/00006231-198501000-00003, indexed in Pubmed: 3916534.
13. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. 
Clinical practice guideline for the evaluation and management of chronic 
kidney disease. Kidney Int. ; 3(1): 1–150.
14. Levey A. A More Accurate Method To Estimate Glomerular Filtration Rate 
from Serum Creatinine: A New Prediction Equation. Annals of Internal Medi-
cine. 1999; 130(6): 461, doi: 10.7326/0003-4819-130-6-199903160-00002.
15. Dias AH, Pintão S, Almeida P, et al. Comparison of GFR calculation methods: 
MDRD and CKD-EPI vs. (99m)Tc-DTPA tracer clearance rates. Scand J Clin 
Lab Invest. 2013; 73(4): 334–338, doi: 10.3109/00365513.2013.780663, 
indexed in Pubmed: 23586782.
